Alpha-9 Oncology is a biotechnology company developing imaging and therapeutic molecules for the treatment of solid and hematologic cancers.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.10.2024 | Series C | $175M | - |
Mentions in press and media 2
| Date | Title | Description |
| 23.10.2024 | Alpha-9 Oncology Raises $175M in Series C Financing | Alpha-9 Oncology Inc., a Boston, MA- and Vancouver, Canada-based clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, raised $175m in Series C financing.
The round was le... |
| 23.10.2024 | Alpha-9 raises $175M series C to bankroll clinical-stage radiopharma pipeline | Alpha-9 Oncology has raised a $175 million series C round to bankroll its clinical-stage radiopharmaceutical drugs, although the exact details of the biotech’s pipeline remain hazy for now.
The Canadian company said it had already establish... |
Reviews 0
